Skip to main content
Log in

Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The objective of the present study was to verify whether chronic renal patients on hemodialysis (HD) with residual diuresis who were using small doses of furosemide present different levels of urinary volume and sodium excretion compared to patients with residual diuresis who do not use this drug.

Methods

We studied 19 chronic renal patients on HD who presented any level of residual diuresis. Urine was collected during the 24-h interdialytic period, and physical examinations and blood sampling took place immediately before the start of HD. Patients were divided into two groups: the diuretic group (DG, n = 10), in which patients had been using 40 mg of furosemide for at least 3 months, and the non-diuretic group (NDG, n = 9), in which patients used no diuretics.

Results

Although both groups presented the same average glomerular filtration rate (p > 0.05) and time in dialysis (p > 0.05) the DG presented an average of twice the urinary volume in 24 h (1142 ± 184 vs. 453 ± 135 ml/24 h, respectively; p = 0.008) and double the total excreted sodium mass compared to patients in the NDG (112 ± 22.4 vs. 45.2 ± 16.0 mEq/24 h, respectively; p = 0.02).

Conclusion

The results of this study have shown that chronic use of small doses of furosemide in chronic renal patients with residual diuresis could increase urinary volume and sodium excretion compared to patients who did not use this drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 2 Suppl 1:S1–266.

    Google Scholar 

  3. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1983;19:397–403.

    PubMed  CAS  Google Scholar 

  4. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991;37(4):598–604.

    PubMed  CAS  Google Scholar 

  5. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556–64.

    PubMed  CAS  Google Scholar 

  6. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001;59(3):1128–33.

    Article  CAS  PubMed  Google Scholar 

  7. Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial. 2004;17(3):196–201.

    Article  PubMed  Google Scholar 

  8. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis. 2007;49(3):426–31.

    Article  PubMed  Google Scholar 

  9. Krediet RT, Douma CE, van Olden RW, Ho-dac-Pannekeet MM, Struijk DG. Augmenting solute clearance in peritoneal dialysis. Kidney Int. 1998;54(6):2218–25.

    Article  CAS  PubMed  Google Scholar 

  10. Boesken WH, Kult J. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Clin Nephrol. 1997;48(1):22–8.

    PubMed  CAS  Google Scholar 

  11. van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol. 1992;12(5):351–6.

    Article  PubMed  Google Scholar 

  12. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309(25):1543–6.

    Article  CAS  PubMed  Google Scholar 

  13. Katopodis KP, Chasiotis G, Nikolopoulos P, Seferiadis K, Siamopoulos KC. The influence of 24 h urine sampling on the evaluation of renal dysfunction. Nephrol Dial Transplant. 2007;22(11):3360–2.

    Article  CAS  PubMed  Google Scholar 

  14. Rose B. Pathophysiology of renal disease. New York: McGraw-Hill; 1987.

    Google Scholar 

  15. Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E. Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant. 2001;16(4):776–82.

    Article  CAS  PubMed  Google Scholar 

  16. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745–50.

    PubMed  Google Scholar 

  17. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989;36(4):682–9.

    Article  CAS  PubMed  Google Scholar 

  18. Russo D, Memoli B, Andreucci VE. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol. 1992;38(Suppl 1):S69–73.

    PubMed  Google Scholar 

  19. Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology (Carlton). 2008;13(3):247–50.

    Article  CAS  Google Scholar 

  20. Schmidt P, Loew D, Dycka J, Kopsa H, Balcke P, Zazgornik J, Deutsch E. Comparison of the effects of muzolimine and furosemide in patients with end stage renal failure on chronic dialysis. Eur J Clin Pharmacol. 1981;20(1):23–6.

    Article  CAS  PubMed  Google Scholar 

  21. van Olden RW, van Meyel JJ, Gerlag PG. Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency. Eur J Clin Pharmacol. 1995;47(6):483–8.

    Article  PubMed  Google Scholar 

  22. Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int. 2003;64(2):632–40.

    Article  CAS  PubMed  Google Scholar 

  23. Van Stone J. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J. 1995;41(3):M713–6.

    Article  PubMed  Google Scholar 

  24. Hakim RM. Clinical implications of biocompatibility in blood purification membranes. Nephrol Dial Transplant. 2000;15(Suppl 2):16–20.

    Article  PubMed  Google Scholar 

  25. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl. 2000;76:S104–11.

    Article  CAS  PubMed  Google Scholar 

  26. Smeby LC, Wideroe TE, Balstad T, Jorstad S. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purif. 1986;4(1–3):93–101.

    Article  CAS  PubMed  Google Scholar 

  27. Brater DC, Anderson SA, Brown-Cartwright D. Response to furosemide in chronic renal insufficiency: rationale for limited doses. Clin Pharmacol Ther. 1986;40(2):134–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastião R. Ferreira-Filho.

About this article

Cite this article

Lemes, H.P., Araujo, S., Nascimento, D. et al. Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol 15, 554–559 (2011). https://doi.org/10.1007/s10157-011-0427-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-011-0427-z

Keywords

Navigation